STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1912 by analyst upside · 2026-06-30
HQY
HealthEquity, Inc.
Healthcare · Market Cap $7B · P/E 32.9x
ANALYST PRICE TARGET
+31.6%
implied upside to consensus target
Current Price $87.81
Consensus Target $115.56
Bull Target $135.0
Bear Target $88.0
Analysts Covering 16
ANALYST CONSENSUS - BUY
Strong Buy
5
Buy
9
Hold
1
Sell
1
52-Week Low $72.76
52-Week High $106.6
YTD Return -3.6%
FUNDAMENTALS
Market Cap $7B
P/E Ratio (TTM) 32.9x
Forward P/E 16.0x
EPS (TTM) $2.67
PEG Ratio 1.27
Dividend Yield N/A
Revenue (TTM) $1.3B
Profit Margin 17.3%
52-WEEK RANGE
52-Week Low $72.76
52-Week High $106.6
Current Price $87.81
Bear Target $88.0
Bull Target $135.0
● Now $87.81 ● Target $115.56
TRADING DATA
Avg Volume 1.0M
YTD Return -3.6%
Analyst Count 16
Consensus Buy
Upside to Target +31.6%
Last Updated 2026-06-30

ANALYST SUMMARY

HealthEquity, Inc. (HQY) is currently trading at $87.81 with a Wall Street consensus price target of $115.56, implying potential upside of 31.6% over the next 12 months. 16 analysts currently cover HQY, with a consensus rating of Buy - 88% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $135.0, while the most cautious has a target of $88.0.

HQY operates in the Healthcare sector with a market capitalisation of $7B. The stock is down 3.6% year-to-date and is currently trading near the lower end of its 52-week range of $72.76 – $106.6.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for HQY, with each firm's 90-day track record across all stocks we track. See full firm rankings →

RBC Capital reit
Outperform → Outperform 2026-06-03 Building track record
Citizens — Reiterated
Market Outperform → Market Outperform 2026-06-01 Building track record
RBC Capital — Reiterated
Outperform → Outperform 2026-05-29 Building track record
Barrington Research — Reiterated
Outperform → Outperform 2026-05-22 Building track record
BMO Capital ↑ Upgrade
Market Perform → Outperform 2026-04-09 Building track record
Deutsche Bank — Reiterated
Buy → Buy 2026-03-19 Building track record
Barrington Research — Reiterated
Outperform → Outperform 2026-03-18 Building track record
JP Morgan — Reiterated
Overweight → Overweight 2026-03-18 43% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
63
out of 100
Coverage depth
22/30
Consensus clarity
19/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →